Bay Biosciences provides high-quality, matched fresh frozen bone marrow,  sera (serum), EDTA plasma and peripheral blood mononuclear cells (PBMC’s), bio-fluids from myelofibrosis patients for research.

The sera (serum) and plasma bio-fluid specimens are processed from myelofibrosis patients peripheral whole-blood using customized collection and processing protocols.

Myelofibrosis Overview

Myelofibrosis is a rare type of blood cancer that starts in your marrow, a spongy tissue inside your bones that makes blood cells. The disease causes scars called fibrosis, which affects how many blood cells your body can make.

It causes abnormal development and function of bone marrow cells, leading to scar tissues

Myelofibrosis (MF) is part of a group of conditions called myeloproliferative neoplasms (MPNs).

Other MPNs can also progress to MF. While some people can go years without having symptoms, others have symptoms that get worse due to scarring in their bone marrow.

Myelofibrosis Effects on The Body

The bone marrow consists of tissues responsible for producing blood cells, including red blood cells, white blood cells, and platelets. It is also made up of a network of fibers that support the blood-forming tissues.

Types of Myelofibrosis

Following are two types of MF:

Primary Myelofibrosis

Primary MF develops on its own, causing many blood stem cells to turn into immature blood cells called blasts.

The web of fibers in the bone marrow also becomes abnormally thick, resembling scar tissue, which makes it harder for your body to make new blood cells.

Secondary Myelofibrosis

Secondary MF results from another condition — usually one that affects your bone marrow. This includes polycythemia vera, chronic myeloid leukemia (CML), and essential thrombocythemia.

The end result is the same, and in addition to the symptoms of MF, you would also experience the symptoms of the underlying condition.

Symptoms of Myelofibrosis

Myelofibrosis tends to come on slowly, and many people don’t notice symptoms at first. However, as it progresses and starts to interfere with blood cell production, its symptoms may include:

Causes of Myelofibrosis

Myelofibrosis is associated with a genetic mutation in blood stem cells. However, researchers aren’t sure what causes this mutation.

When the mutated cells replicate and divide, they pass the mutation on to new blood cells. Eventually, the mutated cells overtake the bone marrow’s ability to produce healthy blood cells.

This usually results in too few red blood cells and too many white blood cells. It also causes scarring and hardening of your bone marrow, which is usually soft and spongy.

Prevalence of Myelofibrosis

Myelofibrosis  is a rare condition, occurring in only about 4-6 out of every 100,000 patients in the United States.

Some sources suggest that primary MF is as rare as 0.8-2.1 per 100,000 people yearly. For secondary MF, the prevalence depends on the exact condition causing it.

Risk Factors of Myelofibrosis

However, several things can increase your risk of developing it, including:

  • Age: While individuals of any age can have myelofibrosis, it’s usually diagnosed in patients over the age of 50.
  • Another blood disorder.: Some people develop secondary myelofibrosis as a complication of another condition.
  • Exposure to chemicals: Myelofibrosis has been associated with exposure to certain industrial chemicals, including toluene and benzene.
  • Exposure to radiation: People who’ve been exposed to radioactive material may have an increased chance of developing MF.


Diagnosis of Myelofibrosis

Myelofibrosis usually shows up on a routine complete blood count (CBC). Patients with myelofibrosis tend to have very low levels of red blood cells and unusually high or low levels of white blood cells and platelets.

Based on the results of your CBC test, your doctor might also do a bone marrow biopsy. This involves taking a small sample of your bone marrow and looking at it more closely for signs of myelofibrosis, such as scarring.

You may also need an X-ray or MRI scan to rule out any other potential causes of your symptoms or CBC results.

Treatment of Myelofibrosis

Myelofibrosis treatment usually depends on the types of symptoms you have. Many common MF symptoms are associated with an underlying condition caused by MF, such as anemia or an enlarged spleen.

Treating Anemia

If myelofibrosis is causing severe anemia, the patient may need:

  • Blood transfusions: Regular blood transfusions can increase your red blood cell count and reduce anemia symptoms, such as fatigue and weakness.
  • Corticosteroids: These may be used with androgens to encourage red blood cell production or decrease their destruction.
  • Hormone therapy: A synthetic version of the male hormone androgen may promote red blood cell production in some people.
  • Prescription medications: Immunomodulatory medications, such as thalidomide (Thalomid) and lenalidomide (Revlimid), may improve blood cell counts. They may also help with symptoms of an enlarged spleen.


Treatment of An Enlarged Spleen

If you have an enlarged spleen related to MF that’s causing problems, your doctor might recommend:

  • Radiation therapy: Radiation therapy uses targeted beams to kill cells and reduce the size of the spleen.
  • Chemotherapy: Some chemotherapy drugs may reduce the size of your enlarged spleen.
  • Surgery: A splenectomy is a surgical procedure that removes your spleen. Your doctor might recommend this if you aren’t responding well to other treatments.

Gene Mutation Treatment

A drug called ruxolitinib (Jakafi) was approved by the Food and Drug Administration in 2011 to treat the symptoms associated with MF. Ruxolitinib targets a specific genetic mutation that may be the cause of MF.

In clinical trials, it was shown to reduce the size of enlarged spleens, reduce the symptoms of MF, and improve prognosis.

Additional drugs, Inrebic (fedratinib), Vonjo (pacritinib), and Ojjaara (momelotinib), were approved to treat certain types of MF in 2019, 2022, and 2023, respectively. Like Jakafi, these drugs all fall into the category of Janus Kinase (JAK) inhibitors.

Experimental Treatments

Researchers are working on developing new treatments for MF. While many of these require further study to make sure they’re safe, doctors have started using two new treatments in certain cases:

  • Stem cell transplant: Stem cell transplants have the potential to cure MF and restore bone marrow function. However, the procedure can cause life threatening complications, so it’s usually only done when nothing else works.
  • Interferon-alpha: Interferon-alfa has delayed the formation of scar tissue in the bone marrow of people who receive treatment early on, but more research is needed to determine its long-term safety.


Life Expectancy of Myelofibrosis Patients

It’s difficult to predict the outlook for MF, especially in cases of secondary MF, as it depends on the root cause. In addition, there’s no staging system for Myelofibrosis.

People who are low risk tend to have a median survival of 15 years or longer. Certain factors can lower this time frame, including:

  • Being older than 65
  • Having too few red blood cells, too many white blood cells, or certain immature white blood cells
  • Needing many blood transfusions
  • Having certain chromosomal abnormalities
  • Feeling generalized symptoms such as fever, weight loss, or fatigue

Roughly 10-20% of myelofibrosis cases progress to acute myeloid leukemia (AML), a difficult-to-treat form of cancer with a low survival rate.

Complications of Myelofibrosis

Over time, MF can lead to several complications. Other than AML, they include:

Increased blood pressure in your liver.

Increased blood flow from an enlarged spleen can raise the pressure in the portal vein in your liver, causing a condition called portal hypertension.

This can put too much pressure on smaller veins in your stomach and esophagus, which could lead to excessive bleeding or a ruptured vein.

Tumors

Blood cells can form in clumps outside the bone marrow, causing tumors to grow in other areas of your body.

Depending on where these tumors are located, they can cause a variety of different problems, including seizures, bleeding in the gastric tract, or compression of the spinal cord.

Frequently Asked Questions (FAQs)

Is Myelofibrosis Curable?

There isn’t one single treatment that works the same for every person or every type of myelofibrosis. The only true cure involves a stem cell transplant, but this can also cause complications and needs more research on its safety.

How Painful is Myelofibrosis?

With myelofibrosis, you may feel some discomfort or pain below your ribs on the left side because of the enlarged spleen. It may also cause bone pain, as well as joint pain in some cases. The degree of pain can vary between people.

Do You Lose Weight with Myelofibrosis?

Weight loss can be one of the symptoms of MF. This is usually related to a lower appetite and overall feeling of fullness caused by an enlarged spleen.

Summary

While MF often doesn’t cause symptoms in its early stages, it can eventually lead to serious complications, including more aggressive types of cancer.

Living with MF can be stressful, so you may find it helpful to seek out support from an organization such as the Leukemia and Lymphoma Society or the Myeloproliferative Neoplasm Research Foundation. 

 

Bay Biosciences is a global leader in providing researchers with high quality, clinical grade, fully characterized human tissue samples, bio-specimens, and human bio-fluid collections.

Samples available include cancer (tumor) tissue, cancer serum, cancer plasma, cancer, peripheral blood mononuclear cells (PBMC). and human tissue samples from most other therapeutic areas and diseases.

Bay Biosciences maintains and manages its own biorepository, the human tissue bank (biobank) consisting of thousands of diseased samples (specimens) and from normal healthy donors available in all formats and types.

Our biobank procures and stores fully consented, deidentified and institutional review boards (IRB) approved human tissue samples and matched controls.

All our human tissue collections, human specimens and human bio-fluids are provided with detailed, samples associated patient’s clinical data.

This critical patient’s clinical data includes information relating to their past and current disease, treatment history, lifestyle choices, biomarkers, and genetic information.

Patient’s data is extremely valuable for researchers and is used to help identify new effective treatments (drug discovery & development) in oncology, and other therapeutic areas and diseases.

Bay Biosciences banks wide variety of human tissue samples and biological samples, including cryogenically preserved at – 80°C.

Including fresh frozen tissue samples, tumor tissue samples, formalin-fixed paraffin-embedded (FFPE), tissue slides, with matching human bio-fluids, whole blood and blood-derived products such as serum, plasma and PBMC.

Bay Biosciences is a global leader in collecting and providing human tissue samples according to the specified requirements and customized, tailor-made collection protocols.

Please contact us anytime to discuss your special research projects and customized human tissue sample requirements.

Types of Biospecimens

Bay Biosciences provides human tissue samples (human specimens) from diseased and normal healthy donors which includes:

We can also procure most human bio-specimens, special collections and requests for human samples that are difficult to find. All our human tissue samples are procured through IRB-approved clinical protocols and procedures.

In addition to the standard processing protocols, Bay Biosciences can also provide human plasma, serum, and PBMC bio-fluid samples using custom processing protocols; you buy donor-specific collections in higher volumes and specified sample aliquots from us.

Bay Biosciences also provides human samples from normal healthy donors; volunteers, for controls and clinical research, contact us Now.

  • 日本のお客様は、ベイバイオサイエンスジャパンBay Biosciences Japanまたはhttp://baybiosciences-jp.com/contact/までご連絡ください。